(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 6. Fgfr2 signaling is required for lacrimal gland development.
(A-D) Lacrimal gland development was abrogated in
Fgfr2flox/flox;Le-Cre mutants. The control, but not
Fgfr2 mutants, showed a mature lacrimal gland at birth (A,B) and a
lacrimal bud at E14.5 (C,D, arrow). (E,F) The Fgfr2
mesenchymal knockout did not affect lacrimal gland budding, as shown by
aceto-carmine staining (arrowhead). (G,H) Lack of lacrimal gland
budding and cell proliferation (arrow) in the
Fgfr2flox/flox;Le-Cre mutant conjunctival epithelium
(outlined). (I,J) Fgfr2flox/flox;Le-Cre
mutants lost heparan sulfate 10E4 staining in the fornix of the conjunctival
epithelium (arrow), but not in the ectoderm further away from the eye
(arrowhead). The conjunctival epithelia are outlined. (K,L)
Phospho-Shp2 expression was present in the control lacrimal gland bud (K,
arrow), but lost in the Fgfr2flox/flox;Le-Cre mutants (L,
arrowhead).